Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001968202-24-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-02 | 2024-02-01 | REGN | McCourt Marion | EVP Commercial | S - Sale | $945.61 | -273 | 14.8K | -2% | -$258.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | S | D | 273 | $945.61 | 14,789 | D | — | — |